Expression of PD-L1, tumor mutation burden, cytokine secretion, tumor-infiltrating T cells, B cell infiltrates in the form of tertiary lymphoid structures in tumors, blood immune cells, and gut microbiota have been proposed as predictive biomarkers in the ICI setting [24,25,26,27,28,29]. This evidence concerns the gene CD274 and neoplasm.